Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-10

Clinical Trial Update: Bivalirudin in Late PCI for Oatients With STEMI [Phase 4]

View source ↗

Summary

Clinical trial update for bivalirudin used during late PCI in STEMI patients (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalirudin (bivalirudin)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: STEMI - ST Elevation Myocardial Infarction | Phase 4 | Status: UNKNOWN